@CytokineRelease
well steroids are the standard of care that help 30%.
LOL the standard of care that means 70% die!
I did not state that remestemcel-L is now poised to be the front line treatment after FDA approval.
It's a second line treatment that's clearly approval is being sought for, BUT the reason why the vested interests are so threatened, is they can see the LT writing on the wall.
Eventually steroids will be phased out and remestemcel-L will become prophylactic. They're feeling threatened mate!
Cell Therapy News/Articles, page-17054
-
- There are more pages in this discussion • 767 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.020(1.68%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.18 | $1.912M | 1.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 91648 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 60768 | 10 |
View Market Depth
| Last trade - 10.58am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |